These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy. Durand RE, Aquino-Parsons C. Radiother Oncol; 2006 Aug; 80(2):138-42. PubMed ID: 16916562 [Abstract] [Full Text] [Related]
6. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. Chou SC, Azuma Y, Varia MA, Raleigh JA. Br J Cancer; 2004 Feb 09; 90(3):728-35. PubMed ID: 14760391 [Abstract] [Full Text] [Related]
7. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Nordsmark M, Loncaster J, Chou SC, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA. Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):581-6. PubMed ID: 11173158 [Abstract] [Full Text] [Related]
8. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC, Raleigh JA. Gynecol Oncol; 1998 Nov 01; 71(2):270-7. PubMed ID: 9826471 [Abstract] [Full Text] [Related]
9. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH. Eur J Cancer; 2009 Nov 01; 45(16):2906-14. PubMed ID: 19699082 [Abstract] [Full Text] [Related]
10. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas. Hoogsteen IJ, Peeters WJ, Marres HA, Rijken PF, van den Hoogen FJ, van der Kogel AJ, Kaanders JH. Radiother Oncol; 2005 Aug 01; 76(2):213-8. PubMed ID: 16112214 [Abstract] [Full Text] [Related]
11. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A. Am J Pathol; 2003 Jun 01; 162(6):1789-806. PubMed ID: 12759237 [Abstract] [Full Text] [Related]
13. Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA. Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):569-74. PubMed ID: 11173156 [Abstract] [Full Text] [Related]
18. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. Arcasoy MO, Amin K, Chou SC, Haroon ZA, Varia M, Raleigh JA. Clin Cancer Res; 2005 Jan 01; 11(1):20-7. PubMed ID: 15671524 [Abstract] [Full Text] [Related]
19. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ. Int J Cancer; 2003 Mar 10; 104(1):85-91. PubMed ID: 12532423 [Abstract] [Full Text] [Related]
20. Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors. Haustermans K, Hofland I, Van de Pavert L, Geboes K, Varia M, Raleigh J, Begg AC. Radiother Oncol; 2000 Jun 10; 55(3):325-33. PubMed ID: 10869747 [Abstract] [Full Text] [Related] Page: [Next] [New Search]